{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:44:34Z","timestamp":1769114674741,"version":"3.49.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Society for the Promotion of Research in Experimental Neurology, Vienna, Austria"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00702-023-02660-3","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T12:02:15Z","timestamp":1686571335000},"page":"891-904","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia"],"prefix":"10.1007","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9641-7649","authenticated-orcid":false,"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"key":"2660_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D (2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7:47","journal-title":"Nat Rev Dis Primers"},{"key":"2660_CR2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","volume":"18","author":"I Alafuzoff","year":"2008","unstructured":"Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, Bugiani O, Del-Tredici K, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Ince P, Kamphorst W, King A, Korkolopoulou P, Kovacs GG, Larionov S, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Tagliavini F, Stadelmann C, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H (2008) Staging of neurofibrillary pathology in Alzheimer\u2019s disease: a study of the BrainNet Europe Consortium. Brain Pathol 18:484\u2013496","journal-title":"Brain Pathol"},{"key":"2660_CR3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00401-009-0523-2","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovacs GG, Meyronet D, Monoranu C, Parchi P, Parkkinen L, Patsouris E, Roggendorf W, Rozemuller A, Stadelmann-Nessler C, Streichenberger N, Thal DR, Kretzschmar H (2009) Staging\/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:635\u2013652","journal-title":"Acta Neuropathol"},{"key":"2660_CR4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00401-005-1064-y","volume":"110","author":"J Attems","year":"2005","unstructured":"Attems J, Jellinger KA, Lintner F (2005) Alzheimer\u2019s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol 110:222\u2013231","journal-title":"Acta Neuropathol"},{"key":"2660_CR5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s004010050726","volume":"94","author":"C Bancher","year":"1997","unstructured":"Bancher C, Egensperger R, Kosel S, Jellinger K, Graeber MB (1997) Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementia. Acta Neuropathol 94:403\u2013409","journal-title":"Acta Neuropathol"},{"key":"2660_CR6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL 3rd, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG, Arizona Parkinson\u2019s Disease Consortium t (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613\u2013634","journal-title":"Acta Neuropathol"},{"key":"2660_CR7","doi-asserted-by":"crossref","first-page":"fcab80","DOI":"10.1093\/braincomms\/fcab180","volume":"3","author":"R Biundo","year":"2021","unstructured":"Biundo R, Weis L, Fiorenzato E, Pistonesi F, Cagnin A, Bertoldo A, Anglani M, Cecchin D, Antonini A (2021) The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study. Brain Commun 3:fcab80","journal-title":"Brain Commun"},{"key":"2660_CR8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"2660_CR9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"2660_CR10","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","volume":"64","author":"H Braak","year":"2005","unstructured":"Braak H, R\u00fcb U, Jansen Steur EN, Del Tredici K, de Vos RA (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64:1404\u20131410","journal-title":"Neurology"},{"key":"2660_CR11","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1161\/STROKEAHA.111.623462","volume":"42","author":"AS Buchman","year":"2011","unstructured":"Buchman AS, Leurgans SE, Nag S, Bennett DA, Schneider JA (2011) Cerebrovascular disease pathology and parkinsonian signs in old age. Stroke 42:3183\u20133189","journal-title":"Stroke"},{"key":"2660_CR12","doi-asserted-by":"crossref","first-page":"e1821","DOI":"10.1212\/WNL.0000000000007315","volume":"92","author":"AS Buchman","year":"2019","unstructured":"Buchman AS, Yu L, Wilson RS, Leurgans SE, Nag S, Shulman JM, Barnes LL, Schneider JA, Bennett DA (2019) Progressive Parkinsonism in older adults is related to the burden of mixed brain pathologies. Neurology 92:e1821\u2013e1830","journal-title":"Neurology"},{"key":"2660_CR13","doi-asserted-by":"crossref","unstructured":"Carceles-Cordon M, Weintraub D, Chen-Plotkin AS (2023) Cognitive heterogeneity in Parkinson\u2019s disease: A mechanistic view. Neuron 111:1531\u20131546","DOI":"10.1016\/j.neuron.2023.03.021"},{"key":"2660_CR14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neurobiolaging.2021.08.020","volume":"109","author":"D Chariss\u00e9","year":"2022","unstructured":"Chariss\u00e9 D, Erus G, Pomponio R, Gorges M, Schmidt N, Schneider C, Liepelt-Scarfone I, Riedel O, Reetz K, Schulz JB, Berg D, Storch A, Witt K, Dodel R, Kalbe E, Kassubek J, Hilker-Roggendorf R, Baudrexel S (2022) Brain age and Alzheimer\u2019s-like atrophy are domain-specific predictors of cognitive impairment in Parkinson\u2019s disease. Neurobiol Aging 109:31\u201342","journal-title":"Neurobiol Aging"},{"key":"2660_CR15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","volume":"53","author":"R Chia","year":"2021","unstructured":"Chia R, Sabir MS, Bandres-Ciga S, Saez-Atienzar S, Reynolds RH, Gustavsson E, Walton RL, Ahmed S, Viollet C, Ding J, Makarious MB, Diez-Fairen M, Portley MK, Shah Z, Abramzon Y, Hernandez DG, Blauwendraat C, Stone DJ, Eicher J, Parkkinen L, Ansorge O, Clark L, Honig LS, Marder K, Lemstra A, St George-Hyslop P, Londos E, Morgan K, Lashley T, Warner TT, Jaunmuktane Z, Galasko D, Santana I, Tienari PJ, Myllykangas L, Oinas M, Cairns NJ, Morris JC, Halliday GM, Van Deerlin VM, Trojanowski JQ, Grassano M, Calvo A, Mora G, Canosa A, Floris G, Bohannan RC, Brett F, Gan-Or Z, Geiger JT, Moore A, May P, Kr\u00fcger R, Goldstein DS, Lopez G, Tayebi N, Sidransky E, Norcliffe-Kaufmann L, Palma JA, Kaufmann H, Shakkottai VG, Perkins M, Newell KL, Gasser T, Schulte C, Landi F, Salvi E, Cusi D, Masliah E, Kim RC, Caraway CA, Monuki ES, Brunetti M, Dawson TM, Rosenthal LS, Albert MS, Pletnikova O, Troncoso JC, Flanagan ME, Mao Q, Bigio EH, Rodr\u00edguez-Rodr\u00edguez E, Infante J, Lage C, Gonz\u00e1lez-Aramburu I, Sanchez-Juan P, Ghetti B, Keith J, Black SE, Masellis M, Rogaeva E, Duyckaerts C, Brice A, Lesage S, Xiromerisiou G, Barrett MJ, Tilley BS, Gentleman S, Logroscino G, Serrano GE, Beach TG, McKeith IG, Thomas AJ, Attems J, Morris CM, Palmer L, Love S, Troakes C, Al-Sarraj S, Hodges AK, Aarsland D, Klein G, Kaiser SM, Woltjer R, Pastor P, Bekris LM, Leverenz JB, Besser LM, Kuzma A, Renton AE, Goate A, Bennett DA, Scherzer CR, Morris HR, Ferrari R, Albani D, Pickering-Brown S, Faber K, Kukull WA, Morenas-Rodriguez E, Lle\u00f3 A, Fortea J, Alcolea D, Clarimon J, Nalls MA, Ferrucci L, Resnick SM, Tanaka T, Foroud TM, Graff-Radford NR, Wszolek ZK, Ferman T, Boeve BF, Hardy JA, Topol EJ, Torkamani A, Singleton AB, Ryten M, Dickson DW, Chi\u00f2 A, Ross OA, Gibbs JR, Dalgard CL, Traynor BJ, Scholz SW (2021) Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet 53:294\u2013303","journal-title":"Nat Genet"},{"key":"2660_CR16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.parkreldis.2020.09.030","volume":"80","author":"KS Chin","year":"2020","unstructured":"Chin KS, Yassi N, Churilov L, Masters CL, Watson R (2020) Prevalence and clinical associations of tau in Lewy body dementias: a systematic review and meta-analysis. Parkinsonism Relat Disord 80:184\u2013193","journal-title":"Parkinsonism Relat Disord"},{"key":"2660_CR17","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/00048674221081773","volume":"57","author":"KS Chin","year":"2023","unstructured":"Chin KS, Gajamange S, Desmond PM, Villemagne VL, Rowe CC, Churilov L, Yassi N, Watson R (2023) Association between amyloid-beta deposition and cortical thickness in dementia with Lewy bodies. Aust N Z J Psychiatry 57:594\u2013602","journal-title":"Aust N Z J Psychiatry"},{"key":"2660_CR18","doi-asserted-by":"crossref","first-page":"e0153989","DOI":"10.1371\/journal.pone.0153989","volume":"11","author":"PY Chiu","year":"2016","unstructured":"Chiu PY, Tsai CT, Chen PK, Chen WJ, Lai TJ (2016) Neuropsychiatric symptoms in Parkinson\u2019s disease dementia are more similar to Alzheimer\u2019s disease than dementia with Lewy bodies: a case-control study. PLoS ONE 11:e0153989","journal-title":"PLoS ONE"},{"key":"2660_CR19","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","volume":"30","author":"LK Clinton","year":"2010","unstructured":"Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM (2010) Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 30:7281\u20137289","journal-title":"J Neurosci"},{"key":"2660_CR20","first-page":"216","volume":"76","author":"M Colom-Cadena","year":"2017","unstructured":"Colom-Cadena M, Grau-Rivera O, Planellas L, Cerquera C, Morenas E, Helgueta S, Mu\u00f1oz L, Kulisevsky J, Mart\u00ed MJ, Tolosa E, Clarimon J, Lle\u00f3 A, Gelpi E (2017) Regional overlap of pathologies in Lewy body disorders. J Neuropathol Exp Neurol 76:216\u2013224","journal-title":"J Neuropathol Exp Neurol"},{"key":"2660_CR21","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","volume":"134","author":"Y Compta","year":"2011","unstructured":"Compta Y, Parkkinen L, O\u2019Sullivan SS, Vandrovcova J, Holton JL, Collins C, Lashley T, Kallis C, Williams DR, de Silva R, Lees AJ, Revesz T (2011) Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important? Brain 134:1493\u20131505","journal-title":"Brain"},{"key":"2660_CR22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3233\/JAD-201548","volume":"80","author":"C Cong","year":"2021","unstructured":"Cong C, Zhang W, Qian X, Qiu W, Ma C (2021) Significant overlap of alpha-synuclein, amyloid-beta, and phospho-tau pathologies in neuropathological diagnosis of Lewy-related pathology. J Alzheimers Dis 80:447\u2013458","journal-title":"J Alzheimers Dis"},{"key":"2660_CR23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ana.25392","volume":"85","author":"D Coughlin","year":"2019","unstructured":"Coughlin D, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, McMillan CT, Wolk DA, Akhtar RS, Hurtig HI, Branch Coslett H, Hamilton RH, Siderowf AD, Duda JE, Rascovsky K, Lee EB, Lee VM, Grossman M, Trojanowski JQ, Irwin DJ (2019) Cognitive and pathological influences of tau pathology in Lewy body disorders. Ann Neurol 85:259\u2013271","journal-title":"Ann Neurol"},{"key":"2660_CR24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mds.27867","volume":"35","author":"DG Coughlin","year":"2020","unstructured":"Coughlin DG, Hurtig HI, Irwin DJ (2020) Pathological influences on clinical heterogeneity in Lewy body diseases. Mov Disord 35:5\u201319","journal-title":"Mov Disord"},{"key":"2660_CR25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3233\/JPD-191600","volume":"9","author":"LJ de Schipper","year":"2019","unstructured":"de Schipper LJ, Hafkemeijer A, van der Grond J, Marinus J, Henselmans JML, van Hilten JJ (2019) Regional structural hippocampal differences between dementia with Lewy bodies and Parkinson\u2019s disease. J Parkinsons Dis 9:775\u2013783","journal-title":"J Parkinsons Dis"},{"key":"2660_CR26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00002093-200101000-00005","volume":"15","author":"T Del Ser","year":"2001","unstructured":"Del Ser T, Hachinski V, Merskey H, Munoz DG (2001) Clinical and pathologic features of two groups of patients with dementia with Lewy bodies: effect of coexisting Alzheimer-type lesion load. Alzheimer Dis Assoc Disord 15:31\u201344","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2660_CR27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.jnen.0000205145.54457.ea","volume":"65","author":"V Deramecourt","year":"2006","unstructured":"Deramecourt V, Bombois S, Maurage CA, Ghestem A, Drobecq H, Vanmechelen E, Lebert F, Pasquier F, Delacourte A (2006) Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol 65:278\u2013288","journal-title":"J Neuropathol Exp Neurol"},{"key":"2660_CR28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamapsychiatry.2021.4363","volume":"79","author":"DP Devanand","year":"2022","unstructured":"Devanand DP, Lee S, Huey ED, Goldberg TE (2022) Associations between neuropsychiatric symptoms and neuropathological diagnoses of Alzheimer disease and related dementias. JAMA Psychiat 79:359\u2013367","journal-title":"JAMA Psychiat"},{"key":"2660_CR29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.parkreldis.2014.02.012","volume":"20","author":"BN Dugger","year":"2014","unstructured":"Dugger BN, Adler CH, Shill HA, Caviness J, Jacobson S, Driver-Dunckley E, Beach TG (2014) Concomitant pathologies among a spectrum of parkinsonian disorders. Parkinsonism Relat Disord 20:525\u2013529","journal-title":"Parkinsonism Relat Disord"},{"key":"2660_CR30","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22:1689\u20131707","journal-title":"Mov Disord"},{"key":"2660_CR31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JPD-181367","volume":"8","author":"SM Fereshtehnejad","year":"2018","unstructured":"Fereshtehnejad SM, L\u00f6kk J, Wimo A, Eriksdotter M (2018) No significant difference in cognitive decline and mortality between Parkinson\u2019s disease dementia and dementia with Lewy bodies: naturalistic longitudinal data from the Swedish Dementia Registry. J Parkinsons Dis 8:553\u2013561","journal-title":"J Parkinsons Dis"},{"key":"2660_CR32","doi-asserted-by":"crossref","first-page":"e846","DOI":"10.1212\/WNL.0000000000201579","volume":"100","author":"D Ferreira","year":"2023","unstructured":"Ferreira D, Przybelski SA, Lesnick TG, Schwarz CG, Diaz-Galvan P, Graff-Radford J, Senjem ML, Fields JA, Knopman DS, Jones DT, Savica R, Ferman TJ, Graff-Radford N, Lowe VJ, Jack CR, Petersen RC, Westman E, Boeve BF, Kantarci K (2023) Cross-sectional associations of beta-amyloid, tau, and cerebrovascular biomarkers with neurodegeneration in probable dementia with Lewy bodies. Neurology 100:e846\u2013e859","journal-title":"Neurology"},{"key":"2660_CR33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3233\/ADR220114","volume":"20","author":"DW Fisher","year":"2023","unstructured":"Fisher DW, Tulloch J, Yu C-E, Tsuang D (2023) A preliminary comparison of the methylome and transcriptome from the prefrontal cortex across Alzheimer\u2019s disease and Lewy body dementia. J Alzheimers Dis Rep 20:279\u2013297","journal-title":"J Alzheimers Dis Rep"},{"key":"2660_CR34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"2660_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gaitpost.2016.08.009","volume":"50","author":"NE Fritz","year":"2016","unstructured":"Fritz NE, Kegelmeyer DA, Kloos AD, Linder S, Park A, Kataki M, Adeli A, Agrawal P, Scharre DW, Kostyk SK (2016) Motor performance differentiates individuals with Lewy body dementia, Parkinson\u2019s and Alzheimer\u2019s disease. Gait Posture 50:1\u20137","journal-title":"Gait Posture"},{"key":"2660_CR36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2010.09.036","volume":"486","author":"H Fujishiro","year":"2010","unstructured":"Fujishiro H, Iseki E, Higashi S, Kasanuki K, Murayama N, Togo T, Katsuse O, Uchikado H, Aoki N, Kosaka K, Arai H, Sato K (2010) Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia. Neurosci Lett 486:19\u201323","journal-title":"Neurosci Lett"},{"key":"2660_CR37","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1082324","volume":"300","author":"BI Giasson","year":"2003","unstructured":"Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, Trojanowski JQ, Lee VM (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300:636\u2013640","journal-title":"Science"},{"issue":"Suppl 2","key":"2660_CR38","first-page":"S81","volume":"64","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Emre M, Dubois B (2008) Parkinson\u2019s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol 64(Suppl 2):S81-92","journal-title":"Ann Neurol"},{"key":"2660_CR39","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000441421","volume":"16","author":"SN Gomperts","year":"2016","unstructured":"Gomperts SN, Marquie M, Locascio JJ, Bayer S, Johnson KA, Growdon JH (2016) PET radioligands reveal the basis of dementia in Parkinson\u2019s disease and dementia with Lewy bodies. Neurodegener Dis 16:118\u2013124","journal-title":"Neurodegener Dis"},{"key":"2660_CR40","doi-asserted-by":"crossref","first-page":"117184","DOI":"10.1016\/j.neuroimage.2020.117184","volume":"221","author":"J Gratwicke","year":"2020","unstructured":"Gratwicke J, Oswal A, Akram H, Jahanshahi M, Hariz M, Zrinzo L, Foltynie T, Litvak V (2020) Resting state activity and connectivity of the nucleus basalis of Meynert and globus pallidus in Lewy body dementia and Parkinson\u2019s disease dementia. Neuroimage 221:117184","journal-title":"Neuroimage"},{"key":"2660_CR41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","volume":"154","author":"JL Guo","year":"2013","unstructured":"Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B, Riddle DM, Kwong LK, Xu Y, Trojanowski JQ, Lee VM (2013) Distinct alpha-synuclein strains differentially promote tau inclusions in neurons. Cell 154:103\u2013117","journal-title":"Cell"},{"key":"2660_CR42","unstructured":"Haider A, Spurling BC, S\u00e1nchez-Manso JC (2022) Lewy Body Dementia. In: StatPearls [Internet], 2020\/07\/11 Edition. StatPearls Publishing Treasure Island (FL), https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482441\/"},{"key":"2660_CR43","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00702-011-0641-6","volume":"118","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Song YJ, Harding AJ (2011) Striatal beta-amyloid in dementia with Lewy bodies but not Parkinson\u2019s disease. J Neural Transm 118:713\u2013719","journal-title":"J Neural Transm (vienna)"},{"key":"2660_CR44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-7091-6846-2_7","volume":"51","author":"LA Hansen","year":"1997","unstructured":"Hansen LA (1997) The Lewy body variant of Alzheimer disease. J Neural Transm Suppl 51:83\u201393","journal-title":"J Neural Transm Suppl"},{"key":"2660_CR45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/nan.12648","volume":"47","author":"D Hansen","year":"2021","unstructured":"Hansen D, Ling H, Lashley T, Foley JA, Strand C, Eid TM, Holton JL, Warner TT (2021) Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson\u2019s disease dementia. Neuropathol Appl Neurobiol 47:143\u2013156","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2660_CR46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2017.09.009","volume":"44","author":"MG Heckman","year":"2017","unstructured":"Heckman MG, Kasanuki K, Diehl NN, Koga S, Soto A, Murray ME, Dickson DW, Ross OA (2017) Parkinson\u2019s disease susceptibility variants and severity of Lewy body pathology. Parkinsonism Relat Disord 44:79\u201384","journal-title":"Parkinsonism Relat Disord"},{"key":"2660_CR47","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord 23:837\u2013844","journal-title":"Mov Disord"},{"key":"2660_CR48","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnen\/nlw070","volume":"75","author":"DH Hepp","year":"2016","unstructured":"Hepp DH, Vergoossen DL, Huisman E, Lemstra AW, Berendse HW, Rozemuller AJ, Foncke EM, van de Berg WD (2016) Distribution and load of amyloid-beta pathology in Parkinson disease and dementia with Lewy bodies. J Neuropathol Exp Neurol 75:936\u2013945","journal-title":"J Neuropathol Exp Neurol"},{"key":"2660_CR49","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/ene.15211","volume":"29","author":"Z Hijazi","year":"2021","unstructured":"Hijazi Z, Yassi N, O\u2019Brien JT, Watson R (2021) The influence of cerebrovascular disease in dementia with Lewy bodies and Parkinson\u2019s disease dementia. Eur J Neurol 29:1254\u20131265","journal-title":"Eur J Neurol"},{"issue":"Suppl 1","key":"2660_CR50","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1017\/cjn.2016.2","volume":"43","author":"DB Hogan","year":"2016","unstructured":"Hogan DB, Fiest KM, Roberts JI, Maxwell CJ, Dykeman J, Pringsheim T, Steeves T, Smith EE, Pearson D, Jette N (2016) The prevalence and incidence of dementia with Lewy bodies: a systematic review. Can J Neurol Sci 43(Suppl 1):S83-95","journal-title":"Can J Neurol Sci"},{"key":"2660_CR51","doi-asserted-by":"crossref","first-page":"e1855","DOI":"10.1212\/WNL.0000000000011699","volume":"96","author":"E Howard","year":"2021","unstructured":"Howard E, Irwin DJ, Rascovsky K, Nevler N, Shellikeri S, Tropea TF, Spindler M, Deik A, Chen-Plotkin A, Siderowf A, Dahodwala N, Weintraub D, Shaw LM, Trojanowski JQ, Vaishnavi SN, Wolk DA, Mechanic-Hamilton D, Morley JF, Duda JE, Grossman M, Cousins KA (2021) Cognitive profile and markers of AD-type pathology in patients with Lewy body dementias. Neurology 96:e1855\u2013e1864","journal-title":"Neurology"},{"key":"2660_CR52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0404.2004.00292.x","volume":"110","author":"TA Hughes","year":"2004","unstructured":"Hughes TA, Ross HF, Mindham RH, Spokes EG (2004) Mortality in Parkinson\u2019s disease and its association with dementia and depression. Acta Neurol Scand 110:118\u2013123","journal-title":"Acta Neurol Scand"},{"key":"2660_CR53","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","volume":"54","author":"HI Hurtig","year":"2000","unstructured":"Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson\u2019s disease. Neurology 54:1916\u20131921","journal-title":"Neurology"},{"key":"2660_CR54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.23659","volume":"72","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Van Deerlin V, Lee VM, Leverenz JB, Montine TJ, Duda JE, Hurtig HI, Trojanowski JQ (2012) Neuropathologic substrates of Parkinson disease dementia. Ann Neurol 72:587\u2013598","journal-title":"Ann Neurol"},{"key":"2660_CR55","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","volume":"14","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Lee VM, Trojanowski JQ (2013) Parkinson\u2019s disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies. Nat Rev Neurosci 14:626\u2013636","journal-title":"Nat Rev Neurosci"},{"key":"2660_CR56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK, Nelson PT, Jicha GA, Woltjer R, Quinn JF, Kaye J, Leverenz JB, Tsuang D, Longfellow K, Yearout D, Kukull W, Keene CD, Montine TJ, Zabetian CP, Trojanowski JQ (2017) Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16:55\u201365","journal-title":"Lancet Neurol"},{"key":"2660_CR57","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000197890","volume":"24","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA (2009) Significance of brain lesions in Parkinson disease dementia and Lewy body dementia. Front Neurol Neurosci 24:114\u2013125","journal-title":"Front Neurol Neurosci"},{"key":"2660_CR58","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1582-4934.2011.01507.x","volume":"16","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012) Interaction between pathogenic proteins in neurodegenerative disorders. J Cell Mol Med 16:1166\u20131183","journal-title":"J Cell Mol Med"},{"key":"2660_CR59","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00702-017-1821-9","volume":"125","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA (2018) Dementia with Lewy bodies and Parkinson\u2019s disease-dementia: current concepts and controversies. J Neural Transm 125:615\u2013650","journal-title":"J Neural Transm (vienna)"},{"key":"2660_CR60","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00702-021-02345-9","volume":"128","author":"KA Jellinger","year":"2021","unstructured":"Jellinger KA (2021) Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases. J Neural Transm 128:687\u2013699","journal-title":"J Neural Transm (vienna)"},{"key":"2660_CR61","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.parkreldis.2022.05.024","volume":"100","author":"KA Jellinger","year":"2022","unstructured":"Jellinger KA (2022a) Are there morphological differences between Parkinson\u2019s disease-dementia and dementia with Lewy bodies? Parkinsonism Relat Disord 100:24\u201332","journal-title":"Parkinsonism Relat Disord"},{"key":"2660_CR62","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00702-022-02522-4","volume":"129","author":"KA Jellinger","year":"2022","unstructured":"Jellinger KA (2022b) Morphological basis of Parkinson disease-associated cognitive impairment: an update. J Neural Transm 129:977\u2013999","journal-title":"J Neural Transm (vienna)"},{"key":"2660_CR63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00401-006-0088-2","volume":"112","author":"KA Jellinger","year":"2006","unstructured":"Jellinger KA, Attems J (2006) Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol 112:253\u2013260","journal-title":"Acta Neuropathol (berl)"},{"key":"2660_CR64","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00401-008-0347-5","volume":"115","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA, Attems J (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 115:427\u2013436","journal-title":"Acta Neuropathol"},{"key":"2660_CR65","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12916-018-1016-8","volume":"16","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA, Korczyn AD (2018) Are dementia with Lewy bodies and Parkinson\u2019s disease dementia the same disease? BMC Med 16:34","journal-title":"BMC Med"},{"key":"2660_CR66","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.nbd.2010.10.005","volume":"41","author":"ME Kalaitzakis","year":"2011","unstructured":"Kalaitzakis ME, Walls AJ, Pearce RK, Gentleman SM (2011) Striatal Abeta peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes. Neurobiol Dis 41:377\u2013384","journal-title":"Neurobiol Dis"},{"key":"2660_CR67","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","volume":"16","author":"S Koga","year":"2021","unstructured":"Koga S, Sekiya H, Kondru N, Ross OA, Dickson DW (2021) Neuropathology and molecular diagnosis of synucleinopathies. Mol Neurodegener 16:83","journal-title":"Mol Neurodegener"},{"key":"2660_CR68","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/archneurol.2012.1608","volume":"69","author":"PT Kotzbauer","year":"2012","unstructured":"Kotzbauer PT, Cairns NJ, Campbell MC, Willis AW, Racette BA, Tabbal SD, Perlmutter JS (2012) Pathologic accumulation of alpha-synuclein and Abeta in Parkinson disease patients with dementia. Arch Neurol 69:1326\u20131331","journal-title":"Arch Neurol"},{"key":"2660_CR69","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s00259-022-06069-0","volume":"50","author":"F Lanfranchi","year":"2023","unstructured":"Lanfranchi F, Arnaldi D, Miceli A, Mattioli P, D\u2019Amico F, Raffa S, Donegani MI, Chiola S, Massa F, Pardini M, Di Raimondo T, Sambuceti G, Bauckneht M, Nobili F, Morbelli S (2023) Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson\u2019s Disease (PD) and dementia with Lewy bodies (DLB). Eur J Nucl Med Mol Imaging 50:1090\u20131102","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2660_CR70","doi-asserted-by":"crossref","first-page":"e0202044","DOI":"10.1371\/journal.pone.0202044","volume":"13","author":"V Larsson","year":"2018","unstructured":"Larsson V, Torisson G, Londos E (2018) Relative survival in patients with dementia with Lewy bodies and Parkinson\u2019s disease dementia. PLoS ONE 13:e0202044","journal-title":"PLoS ONE"},{"key":"2660_CR71","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-007-0336-0","volume":"115","author":"T Lashley","year":"2008","unstructured":"Lashley T, Holton JL, Gray E, Kirkham K, O\u2019Sullivan SS, Hilbig A, Wood NW, Lees AJ, Revesz T (2008) Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson\u2019s disease patients. Acta Neuropathol 115:417\u2013425","journal-title":"Acta Neuropathol"},{"key":"2660_CR72","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/mds.27252","volume":"33","author":"SH Lee","year":"2018","unstructured":"Lee SH, Cho H, Choi JY, Lee JH, Ryu YH, Lee MS, Lyoo CH (2018) Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases. Mov Disord 33:262\u2013272","journal-title":"Mov Disord"},{"key":"2660_CR73","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp-2016-313775","volume":"88","author":"AW Lemstra","year":"2017","unstructured":"Lemstra AW, de Beer MH, Teunissen CE, Schreuder C, Scheltens P, van der Flier WM, Sikkes SA (2017) Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 88:113\u2013118","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2660_CR74","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2967\/jnumed.109.065870","volume":"50","author":"SM Lim","year":"2009","unstructured":"Lim SM, Katsifis A, Villemagne VL, Best R, Jones G, Saling M, Bradshaw J, Merory J, Woodward M, Hopwood M, Rowe CC (2009) The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies. J Nucl Med 50:1638\u20131645","journal-title":"J Nucl Med"},{"key":"2660_CR75","first-page":"19","volume":"3","author":"S Love","year":"2014","unstructured":"Love S, Chalmers K, Ince P, Esiri M, Attems J, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F, Greenberg S, Mann D, Kehoe PG (2014) Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. Am J Neurodegener Dis 3:19\u201332","journal-title":"Am J Neurodegener Dis"},{"key":"2660_CR76","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.26542","volume":"93","author":"WRW Martin","year":"2023","unstructured":"Martin WRW, Younce JR, Campbell MC, Racette BA, Norris SA, Ushe M, Criswell S, Davis AA, Alfradique-Dunham I, Maiti B, Cairns NJ, Perrin RJ, Kotzbauer PT, Perlmutter JS (2023) Neocortical Lewy body pathology parallels Parkinson\u2019s dementia, but not always. Ann Neurol 93:184\u2013195","journal-title":"Ann Neurol"},{"key":"2660_CR77","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00702-019-02129-2","volume":"127","author":"A Martini","year":"2020","unstructured":"Martini A, Weis L, Schifano R, Pistonesi F, Fiorenzato E, Antonini A, Biundo R (2020) Differences in cognitive profiles between Lewy body and Parkinson\u2019s disease dementia. J Neural Transm 127:323\u2013330","journal-title":"J Neural Transm (vienna)"},{"key":"2660_CR78","doi-asserted-by":"crossref","first-page":"12245","DOI":"10.1073\/pnas.211412398","volume":"98","author":"E Masliah","year":"2001","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L (2001) Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer\u2019s disease and Parkinson\u2019s disease. Proc Natl Acad Sci U S A 98:12245\u201312250","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2660_CR79","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/bpa.12424","volume":"27","author":"KE McAleese","year":"2017","unstructured":"McAleese KE, Walker L, Erskine D, Thomas AJ, McKeith IG, Attems J (2017) TDP-43 pathology in Alzheimer\u2019s disease, dementia with Lewy bodies and ageing. Brain Pathol 27:472\u2013479","journal-title":"Brain Pathol"},{"key":"2660_CR80","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863\u20131872","journal-title":"Neurology"},{"key":"2660_CR81","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O\u2019Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology 89:88\u2013100","journal-title":"Neurology"},{"key":"2660_CR82","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/acn3.51482","volume":"9","author":"RL Miller","year":"2022","unstructured":"Miller RL, Dhavale DD, O\u2019Shea JY, Andruska KM, Liu J, Franklin EE, Buddhala C, Loftin SK, Cirrito JR, Perrin RJ, Cairns NJ, Campbell MC, Perlmutter JS, Kotzbauer PT (2022) Quantifying regional alpha-synuclein, amyloid beta, and tau accumulation in Lewy body dementia. Ann Clin Transl Neurol 9:106\u2013121","journal-title":"Ann Clin Transl Neurol"},{"key":"2660_CR83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311","journal-title":"Acta Neuropathol"},{"key":"2660_CR84","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/jnnp-2020-324606","volume":"92","author":"FPM Oliveira","year":"2021","unstructured":"Oliveira FPM, Walker Z, Walker RWH, Attems J, Castanheira JC, Silva \u00c2, Oliveira C, Vaz S, Silva M, Costa DC (2021) (123)I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson\u2019s disease and Alzheimer\u2019s disease: a new quantitative analysis of autopsy confirmed cases. J Neurol Neurosurg Psychiatry 92:662\u2013667","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2660_CR85","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00415-021-10402-2","volume":"269","author":"RI Orad","year":"2022","unstructured":"Orad RI, Shiner T (2022) Differentiating dementia with Lewy bodies from Alzheimer\u2019s disease and Parkinson\u2019s disease dementia: an update on imaging modalities. J Neurol 269:639\u2013653","journal-title":"J Neurol"},{"key":"2660_CR86","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I (2019) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14:5","journal-title":"Mol Neurodegener"},{"key":"2660_CR87","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1093\/brain\/awac171","volume":"145","author":"L Pan","year":"2022","unstructured":"Pan L, Li C, Meng L, Tian Y, He M, Yuan X, Zhang G, Zhang Z, Xiong J, Chen G (2022) Tau accelerates alpha-synuclein aggregation and spreading in Parkinson\u2019s disease. Brain 145:3454\u20133471","journal-title":"Brain"},{"key":"2660_CR88","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M, Van den Haute C, Melki R, Baekelandt V (2015) alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522:340\u2013344","journal-title":"Nature"},{"key":"2660_CR89","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000375363","volume":"5","author":"M Petrova","year":"2015","unstructured":"Petrova M, Mehrabian-Spasova S, Aarsland D, Raycheva M, Traykov L (2015) Clinical and neuropsychological differences between mild Parkinson\u2019s disease dementia and dementia with Lewy bodies. Dement Geriatr Cogn Dis Extra 5:212\u2013220","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"2660_CR90","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601","journal-title":"Mov Disord"},{"key":"2660_CR91","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00401-009-0501-8","volume":"118","author":"T Revesz","year":"2009","unstructured":"Revesz T, Holton JL, Lashley T, Plant G, Frangione B, Rostagno A, Ghiso J (2009) Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol 118:115\u2013130","journal-title":"Acta Neuropathol"},{"key":"2660_CR92","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/jnnp-2017-316844","volume":"89","author":"G Rizzo","year":"2018","unstructured":"Rizzo G, Arcuti S, Copetti M, Alessandria M, Savica R, Fontana A, Liguori R, Logroscino G (2018) Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 89:358\u2013366","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2660_CR93","first-page":"469","volume-title":"Oxford textbook of old age psychiatry 2e","author":"A Rongve","year":"2013","unstructured":"Rongve A, Aarsland D (2013) Dementia in Parkinson\u2019s disease and dementia with Lewy bodies. In: Dening T, Thomas A (eds) Oxford textbook of old age psychiatry 2e. Oxford Univ. Press, Oxford, pp 469\u2013478"},{"key":"2660_CR94","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/nan.12294","volume":"42","author":"C Ruffmann","year":"2016","unstructured":"Ruffmann C, Calboli FC, Bravi I, Gveric D, Curry LK, de Smith A, Pavlou S, Buxton JL, Blakemore AI, Takousis P, Molloy S, Piccini P, Dexter DT, Roncaroli F, Gentleman SM, Middleton LT (2016) Cortical Lewy bodies and A-beta burden are associated with prevalence and timing of dementia in Lewy body diseases. Neuropathol Appl Neurobiol 42:436\u2013450","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2660_CR95","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3233\/JAD-201187","volume":"80","author":"SG Ryman","year":"2021","unstructured":"Ryman SG, Yutsis M, Tian L, Henderson VW, Montine TJ, Salmon DP, Galasko D, Poston KL (2021) Cognition at each stage of Lewy body disease with co-occurring Alzheimer\u2019s disease pathology. J Alzheimers Dis 80:1243\u20131256","journal-title":"J Alzheimers Dis"},{"key":"2660_CR96","volume":"432","author":"ESC Severiano","year":"2022","unstructured":"Severiano ESC, Alarc\u00e3o J, Pav\u00e3o Martins I, Ferreira JJ (2022) Frequency of dementia in Parkinson\u2019s disease: A systematic review and meta-analysis. J Neurol Sci 432:120077","journal-title":"J Neurol Sci"},{"key":"2660_CR97","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/nan.12308","volume":"42","author":"M Sierra","year":"2016","unstructured":"Sierra M, Gelpi E, Marti MJ, Compta Y (2016) Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum. Neuropathol Appl Neurobiol 42:451\u2013462","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2660_CR98","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1474-4422(11)70307-6","volume":"11","author":"EE Smith","year":"2012","unstructured":"Smith EE, Schneider JA, Wardlaw JM, Greenberg SM (2012) Cerebral microinfarcts: the invisible lesions. Lancet Neurol 11:272\u2013282","journal-title":"Lancet Neurol"},{"key":"2660_CR99","first-page":"1234","volume":"90","author":"C Smith","year":"2019","unstructured":"Smith C, Malek N, Grosset K, Cullen B, Gentleman S, Grosset DG (2019) Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry 90:1234\u20131243","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2660_CR100","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/jnen\/59.8.733","volume":"59","author":"DR Thal","year":"2000","unstructured":"Thal DR, Rub U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K, Braak E, Braak H (2000) Sequence of Abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59:733\u2013748","journal-title":"J Neuropathol Exp Neurol"},{"key":"2660_CR101","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/alz.12814","volume":"19","author":"JB Toledo","year":"2023","unstructured":"Toledo JB, Abdelnour C, Weil RS, Ferreira D, Rodriguez-Porcel F, Pilotto A, Wyman-Chick KA, Grothe MJ, Kane JPM, Taylor A, Rongve A, Scholz S, Leverenz JB, Boeve BF, Aarsland D, McKeith IG, Lewis S, Leroi I, Taylor JP (2023) Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design. Alzheimers Dement 19:318\u2013332","journal-title":"Alzheimers Dement"},{"key":"2660_CR102","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3233\/JAD-210114","volume":"81","author":"Q Tong","year":"2021","unstructured":"Tong Q, Chen L (2021) Associations of Alzheimer\u2019s disease neuropathologic changes with clinical presentations of Parkinson\u2019s disease. J Alzheimers Dis 81:201\u2013207","journal-title":"J Alzheimers Dis"},{"key":"2660_CR103","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","volume":"70","author":"D Tsuang","year":"2013","unstructured":"Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Trojanowski JQ, Weintraub D, Chen-Plotkin AS, Irwin DJ, Rick J, Schellenberg GD, Watson GS, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Quinn JF, Chung KA, Yearout D, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP (2013) APOE epsilon4 increases risk for dementia in pure synucleinopathies. JAMA Neurol 70:223\u2013228","journal-title":"JAMA Neurol"},{"key":"2660_CR104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12868-021-00687-4","volume":"23","author":"H Tu","year":"2022","unstructured":"Tu H, Zhang ZW, Qiu L, Lin Y, Jiang M, Chia SY, Wei Y, Ng ASL, Reynolds R, Tan EK, Zeng L (2022) Increased expression of pathological markers in Parkinson\u2019s disease dementia post-mortem brains compared to dementia with Lewy bodies. BMC Neurosci 23:3","journal-title":"BMC Neurosci"},{"key":"2660_CR105","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00401-020-02157-3","volume":"139","author":"A Van der Perren","year":"2020","unstructured":"Van der Perren A, Gelders G, Fenyi A, Bousset L, Brito F, Peelaerts W, Van den Haute C, Gentleman S, Melki R, Baekelandt V (2020) The structural differences between patient-derived alpha-synuclein strains dictate characteristics of Parkinson\u2019s disease, multiple system atrophy and dementia with Lewy bodies. Acta Neuropathol 139:977\u20131000","journal-title":"Acta Neuropathol"},{"key":"2660_CR106","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","volume":"129","author":"L Walker","year":"2015","unstructured":"Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger K, Attems J (2015) Neuropathologically mixed Alzheimer\u2019s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol 129:729\u2013748","journal-title":"Acta Neuropathol"},{"key":"2660_CR107","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/jnc.14698","volume":"150","author":"L Walker","year":"2019","unstructured":"Walker L, Stefanis L, Attems J (2019) Clinical and neuropathological differences between Parkinson\u2019s disease, Parkinson\u2019s disease dementia and dementia with Lewy bodies - current issues and future directions. J Neurochem 150:467\u2013474","journal-title":"J Neurochem"},{"key":"2660_CR108","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.12688\/f1000research.11725.1","volume":"6","author":"RS Weil","year":"2017","unstructured":"Weil RS, Lashley TL, Bras J, Schrag AE, Schott JM (2017) Current concepts and controversies in the pathogenesis of Parkinson\u2019s disease dementia and Dementia with Lewy Bodies. F1000Res 6:1604","journal-title":"F1000Res"},{"key":"2660_CR109","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/brain\/awr277","volume":"135","author":"D Weintraub","year":"2012","unstructured":"Weintraub D, Dietz N, Duda JE, Wolk DA, Doshi J, Xie SX, Davatzikos C, Clark CM, Siderowf A (2012) Alzheimer\u2019s disease pattern of brain atrophy predicts cognitive decline in Parkinson\u2019s disease. Brain 135:170\u2013180","journal-title":"Brain"},{"key":"2660_CR110","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00415-009-0119-8","volume":"256","author":"CH Williams-Gray","year":"2009","unstructured":"Williams-Gray CH, Goris A, Saiki M, Foltynie T, Compston DA, Sawcer SJ, Barker RA (2009) Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson\u2019s disease. J Neurol 256:493\u2013498","journal-title":"J Neurol"},{"key":"2660_CR111","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102504","volume":"28","author":"EE Wolters","year":"2020","unstructured":"Wolters EE, van de Beek M, Ossenkoppele R, Golla SSV, Verfaillie SCJ, Coomans EM, Timmers T, Visser D, Tuncel H, Barkhof F, Boellaard R, Windhorst AD, van der Flier WM, Scheltens P, Lemstra AW, van Berckel BNM (2020) Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study. Neuroimage Clin 28:102504","journal-title":"Neuroimage Clin"},{"key":"2660_CR112","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1212\/WNL.42.11.2131","volume":"42","author":"E Wu","year":"1992","unstructured":"Wu E, Lipton RB, Dickson DW (1992) Amyloid angiopathy in diffuse Lewy body disease. Neurology 42:2131\u20132135","journal-title":"Neurology"},{"key":"2660_CR113","doi-asserted-by":"crossref","first-page":"1029370","DOI":"10.3389\/fneur.2023.1029370","volume":"14","author":"J Xu","year":"2023","unstructured":"Xu J, Li J, Sun YJ, Quan W, Liu L, Zhang QH, Qin YD, Pei XC, Su H, Chen JJ (2023) Identification of key genes and signaling pathways associated with dementia with Lewy bodies and Parkinson\u2019s disease dementia using bioinformatics. Front Neurol 14:1029370","journal-title":"Front Neurol"},{"key":"2660_CR114","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","volume":"610","author":"Y Yang","year":"2022","unstructured":"Yang Y, Shi Y, Schweighauser M, Zhang X, Kotecha A, Murzin AG, Garringer HJ, Cullinane PW, Saito Y, Foroud T, Warner TT, Hasegawa K, Vidal R, Murayama S, Revesz T, Ghetti B, Hasegawa M, Lashley T, Scheres SHW, Goedert M (2022) Structures of alpha-synuclein filaments from human brains with Lewy pathology. Nature 610:791\u2013795","journal-title":"Nature"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-023-02660-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-023-02660-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-023-02660-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T23:33:39Z","timestamp":1702596819000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-023-02660-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":114,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["2660"],"URL":"https:\/\/doi.org\/10.1007\/s00702-023-02660-3","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,12]]},"assertion":[{"value":"27 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures involving human tissue have been approved by the Ethical Committee of the Medical University of Vienna following the tenants of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}